# A Study of Possibility of Using Regulatory T Cells(VT301) for Treatment of Alzheimer's Disease

> **NCT05016427** · PHASE1 · UNKNOWN · sponsor: **VTBIO Co. LTD** · enrollment: 12 (estimated)

## Conditions studied

- Alzheimer Disease

## Interventions

- **BIOLOGICAL:** VT301

## Key facts

- **NCT ID:** NCT05016427
- **Lead sponsor:** VTBIO Co. LTD
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-11-01
- **Primary completion:** 2021-11-01
- **Final completion:** 2022-04-01
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2021-08-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05016427

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05016427, "A Study of Possibility of Using Regulatory T Cells(VT301) for Treatment of Alzheimer's Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05016427. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*